Last year I had to switch from Symbicort to Advair discus because my monthly copay for Symbicort had risen to almost $400, and my plan didn’t cover the generic. Advair generic was more affordable, about $200 monthly, but still expensive and beyond my means, so I started to get it not through my health insurance but through a drug discount plan that gets its meds from out of the country and takes about a month to get to me, but costs $125 for a three month supply. It’s been tough, so hearing...
Thanks to all who toil for this over the years. I am glad vulnerable people will be able to afford their medications. Long way to go, however, is a start.
First, I'm very sorry Medicare is no longer covering the meds you need. If you haven't already, check for any drug assistance programs that may be able to help lower the cost - Drug Assistance Program Yesterday AAFA met with the White House about inhaler costs. Starting in 2025, the cost of all prescription medicines for people on Medicare will not exceed $2,000 a year. AAFA will keep working with policymakers to take additional steps to lower costs, including through the Medicaid program.
I see in this report that the $35 cap on our asthma medications will be for those with commercial/private insurance or no insurance. Does that mean that those of us with supplemental medication insurance who are on Medicare will still be paying co-pays of over $100 for our inhalers?
Correct, this price cap goes into effect for those with commercial or no insurance. Government insurance is a separate problem that AAFA is still working to address. The pricing system is very complicated and there is still a lot of work to do to ensure everyone has access to affordable asthma medications. Affordable access to healthcare is one of AAFA's key policy issues .
When you block a person, they can no longer invite you to a private message or post to your profile wall. Replies and comments they make will be collapsed/hidden by default. Finally, you'll never receive email notifications about content they create or likes they designate for your content.
Note: if you proceed, you will no longer be following .